New Respiratory Disease Articles from our Partners at Consultant 360

ATS: Guideline for Sarcoidosis Diagnosis and Detection

The guideline includes 14 recommendations and 1 best practice statement on lymph node sampling, screening for extrapulmonary disease, and diagnostic evaluation of suspected extrapulmonary disease.

https://www.consultant360.com/exclusive/pulmonology/interstitial-lung-disease/ats-guideline-sarcoidosis-diagnosis-and-detection 

14 Consensus Statements for PAH Treatment Are Developed

Current guidelines do not provide definitive recommendations for the use of oral prostacyclin pathway agents among patients with pulmonary arterial hypertension. In turn, an expert panel developed consensus statements in an effort to help guide treatment use.

https://www.consultant360.com/exclusive/pulmonology/pulmonary-arterial-hypertension/14-consensus-statements-pah-treatment-are 

Vitamin D Levels Influence COPD Exacerbations

Because the relationship between 25-hydroxyvitamin D and COPD outcomes is unclear, researchers analyzed data from SPIROMICS to determine any associations between baseline 25-OH-vitamin D, cross-sectional and longitudinal lung function, and COPD exacerbations.

https://www.consultant360.com/exclusive/pulmonology/copd/vitamin-d-levels-influence-copd-exacerbations 

ATS: Guideline for Pharmacologic Management of COPD

The guideline includes 6 recommendations that address significant COPD management issues, including how to treat patients with COPD who report having exercise intolerance or dyspnea.

https://www.consultant360.com/exclusive/pulmonology/copd/ats-guideline-pharmacologic-management-copd 

ATS Releases Consensus on Hydroxychloroquine Use, Other Treatment Methods

The American Thoracic Society-led international task force developed suggestions to provide interim guidance for therapeutic interventions for patients with COVID-19.

https://www.consultant360.com/exclusive/pulmonology/ats-releases-consensus-hydroxychloroquine-use-other-treatment-methods